Uncertainty in assessing value of oncology treatments.

The oncologist

Volumn 15 Suppl 1, Issue , 2010, Pages 58-64

  Mullins, C Daniel ^a   Montgomery, Russ ^b   Tunis, Sean ^b  

^a Center for Medical Technology Policy   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DECISION MAKING; DOCTOR PATIENT RELATION; FOOD AND DRUG ADMINISTRATION; HUMAN; MEDICAL RESEARCH; NEOPLASM; ORGANIZATION AND MANAGEMENT; PATIENT PARTICIPATION; RANDOMIZED CONTROLLED TRIAL; REIMBURSEMENT; UNCERTAINTY; UNITED STATES;

BIOMEDICAL RESEARCH; CLINICAL TRIALS AS TOPIC; COST-BENEFIT ANALYSIS; DECISION MAKING; HUMANS; MARYLAND; NEOPLASMS; PATIENT PARTICIPATION; PHYSICIAN-PATIENT RELATIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REIMBURSEMENT MECHANISMS; UNCERTAINTY; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 77954651388     PISSN: None     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2010-S1-58     Document Type: Article

References (0)